These highlights do not include all the information needed to use SAMSCA safely and effectively. See full prescribing information for SAMSCA.
SAMSCA ® (tolvaptan) tablets for oral use
Initial U.S. Approval: 05/2009
WARNING: INITIATE AND RE-INITIATE IN A HOSPITAL AND MONITOR SERUM SODIUM
See full prescribing information for complete boxed warning.
-
SAMSCA should be initiated and re-initiated in patients only in a hospital where serum sodium can be monitored closely.
-
Too rapid correction of hyponatremia (e.g., >12 mEq/L/24 hours) can cause osmotic demyelination resulting in dysarthria, mu
